Perthera seeks to be the precision medicine partner on the patient’s cancer care team.
Recent breakthroughs in cellular protein analysis (proteomics) and gene profiling (genomics) make it possible for Perthera to more completely understand the nature and progression of your cancer. There are many new tests available that can give us insight into your disease, and we select the best available tests to obtain a comprehensive disease profile.
Perthera uses advanced, commercially available tests to provide your oncologist the most complete information available today for fighting your cancer.
Perthera is the only company that safeguards biopsy quality for analysis and takes into account proteomics, genomics and your past medical history. We are also the only company to provide clinical trial options tailored specifically to your molecular profile and previous treatment history.
We use an advanced expert system, an extensive clinical knowledge base, and an expert medical review panel to thoroughly understand your unique cancer and provide options to you and your physician.
Perthera provides a comprehensive report, incorporating all genomic, proteomic test results and expert review of your clinical history to enable you and your oncologist to make the best treatment decisions for you.
Location: United States, Virginia, McLean
Funding Rounds 1
Mentions in press and media 9